Abstract:BACKGROUND: With the increasing use of donation after cardiac death (DCD), especially of the graft liver with steatosis or other pathological changes, the frequency of postreperfusion hyperkalemia in liver transplantation has increased significantly. The present study aimed to determine the factors associated with developing postreperfusion hyperkalemia in liver transplantation from DCD.METHODS: One hundred thirty-one consecutive adult patients who underwent orthotopic liver transplantation from DCD were retrospectively studied. Based on serum potassium within 5 minutes after reperfusion, recipients were divided into two groups: hyperkalemia and normokalemia. According to preoperative biopsy results, the DCD graft livers were classified into five categories. Univariate analysis was performed using CM-square test to identify variables that were significantly different between two groups. Multivariate logistic regression was used to confirm the risk factors of developing hyperkalemia and postreperfusion syndrome. Correlation analysis was used to identify the relationship between the serum concentration of potassium within 5 minutes after re perfusion and the difference in mean arterial pressure values before and within 5 minutes after reperfusion.RESULTS: Twenty-two of 131 liver recipients had hyperkalemia episodes within 5 minutes after reperfusion. The rate of hyperkalemia was significantly higher in recipients of macrosteatotic DCD graft liver (78.6%, P<0.001) than that in recipients of non-macrosteatotic DCD graft liver. The odds ratio of developing postreperfusion hyperkalemia in recipients of macrosteatotic DCD graft liver was 51.3 (P<0.001). Macrosteatosis in the DCD graft liver was an independent risk factor of developing hyperkalemia within 5 minutes after reperfusion. The highest rate of postreperfusion syndrome also occurred in the recipients with macrosteatotic DCD graft liver (71.4%, P<0.001). A strong relationship existed between the serum potassium within 5 minutes after reperfusion and the difference in mean arterial pressure values before and within 5 minutes after reperfusion in macrosteatotic DCD graft liver recipients.CONCLUSION: Macrosteatosis in the DCD graft liver was an independent risk factor of developing hyperkalemia and postreperfusion syndrome in the recipients.

Potential Etiopathogenesis of Seventh Day Syndrome Following Living Donor Liver Transplantation: Ischemia of the Graft?

[Clinical Features and Treatment of Seventh Day Syndrome Following Living Donor Liver Transplantation].

Seventh Day Syndrome Revisited: Early Recognition of the Clinical Syndrome and an Evolving Understanding of Its Etiology

Liver Grafts for Transplantation from Donors with Diabetes: an Analysis of the Scientific Registry of Transplant Recipients Database

The Morbidity and Survival of 196 Consecutive Cases Undergoing Liver Transplantation in a Single Center in Mainland China: Ten-Year Experience.

Predictors of Patient Survival Following Living Donor Liver Transplantation

The early liver function recovery in living liver transplantation donors

Analysis of risk factors of initial poor graft function after living donor liver transplantation

[Analysis of Risk Factors for Marginal Donors in Living Donor Liver Transplantation.].

The early postoperative complications in living liver transplantation donors

Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation.

[Analysis and Management of Postoperative Complication from the Donor of Living Liver Transplantation].

Warm Ischemia Time and Elevated Serum Uric Acid Are Associated with Metabolic Syndrome after Liver Transplantation with Donation after Cardiac Death

Impact of Graft Steatosis on the Post-transplantation Biliary Complications for Living Donor Liver Transplant Recipients in China

Postreperfusion Hyperkalemia in Liver Transplantation Using Donation after Cardiac Death Grafts with Pathological Changes

Risk factors of early allograft dysfunction in 49 cases of liver transplantation from donation after ;cardiac death

Systematic Review of the Safety of Living Liver Donors

Donor Safety in Living Donor Liver Transplantation: a Single-Center Analysis of 300 Cases.

Factors associated with early mortality after living-donor liver transplant.

In-Hospital Mortality After Adult Living Donor Liver Transplantation: Single-Center Experience

[Clinical Analysis of Donor Hepatectomy in Living Donor Liver Transplantation: Report of 74 Cases].